Get startedLog in
    Picture of Innate Pharma SA logo

    IPHA — Innate Pharma SA News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapSucker Stock
    All News

    Brief: Innate Pharma Announces Exclusive Antibody License To Takeda

    Picture of Innate Pharma SA logoInnate Pharma SA
    03/04/2023 06:13
    April 3 (Reuters) - Innate Pharma SA  IPH.PA :
    * INNATE PHARMA ANNOUNCES EXCLUSIVE ANTIBODY LICENSE TO
TAKEDA FOR
RESEARCH PROGRAM IN CELIAC DISEASE
    * TAKEDA OBTAINS EXCLUSIVE WORLDWIDE RIGHTS TO RESEARCH,
DEVELOP,
MANUFACTURE AND COMMERCIALIZE CONJUGATED ANTIBODIES (ADC)
GENERATED FROM SELECTED ANTIBODIES DEVELOPED BY INNATE

Source text for Eikon:  ID:nBw9p06fQa 
Further company coverage:  IPH.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))

    Recent news on Innate Pharma SA

    See all news